As of July 31, 2026, Apptly Health Technologies Corp. carries a market capitalization of 9.27M, placing it among publicly traded companies globally. Its enterprise value stands at 11.62M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 9.27M |
| Enterprise Value | 11.62M |
As of July 31, 2026, Apptly Health Technologies Corp. has 61.79M shares outstanding.
| Shares Outstanding | 61.79M |
These figures are as of July 31, 2026. The price-to-sales ratio is 644.28, and the price-to-book ratio stands at -2.50.
| PS Ratio | 644.28 |
| PB Ratio | -2.50 |
| P/TBV Ratio | -2.50 |
These figures are as of July 31, 2026. The EV/Sales ratio of 808.12 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 11.62M versus a market cap of 9.27M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 808.12 |
As of July 31, 2026, Apptly Health Technologies Corp. maintains a current ratio of 0.05, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -65.15, indicating conservative leverage, while an interest coverage ratio of -9.96 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.05 |
| Quick Ratio | 0.03 |
| Debt / Equity | -65.15 |
| Debt / EBITDA | -2.28 |
| Interest Coverage | -9.96 |
Over the twelve months ended July 31, 2026, Apptly Health Technologies Corp. generated 14,385.00 in revenue and converted that into -548,434.00 in net income, yielding earnings per share of -0.01. EBITDA reached -1.06M, while operating income came in at -1.05M.
| Revenue | 14,385.00 |
| Operating Income | -1.05M |
| Pretax Income | -548,434.00 |
| Net Income | -548,434.00 |
| EBITDA | -1.06M |
| EBIT | -1.06M |
| Earnings Per Share (EPS) | -0.01 |
As of July 31, 2026, Apptly Health Technologies Corp. holds 55,927.00 in cash and equivalents against 2.41M in total debt, resulting in a net debt position of 2.36M. Total book value stands at -3.70M, with working capital of -2.32M providing operational flexibility.
| Cash & Cash Equivalents | 55,927.00 |
| Total Debt | 2.41M |
| Net Debt | 2.36M |
| Equity (Book Value) | -3.70M |
| Book Value Per Share | -0.06 |
| Working Capital | -2.32M |
These figures cover the twelve months ended July 31, 2026. The operating margin of -7,298.44 and net profit margin of -3,812.54 provide insight into operational efficiency.
| Operating Margin | -7,298.44 |
| Pretax Margin | -3,812.54 |
| Profit Margin | -3,812.54 |
| EBITDA Margin | -7,355.66 |
Apptly Health Technologies Corp.'s most recent stock split took place on January 9, 2025 with a 10:1 split ratio.
| Last Split Date | 1/9/2025 |
| Split Ratio | 10:1 |
As of July 31, 2026, Apptly Health Technologies Corp. has an Altman Z-Score of -297.87, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -297.87 |
Already premium?